Biogen (BIIB) Revenue (2009 - 2026)
Biogen's Revenue was $2.74 billion in Q2 2026, up 3.4% from $2.65 billion a year earlier and up 10.4% from the prior quarter.
Powered by 
Analysis
Biogen (BIIB) Revenue (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Biogen's Revenue was $10.03 billion through Jun 30, 2026, up 0.3% year-over-year; for FY2025, it came in at $9.89 billion, up 2.2% from FY2024.
- Revenue shows a five-year compound annual growth rate of -6.0% (FY2020 to FY2025).
- In earlier years, Revenue was $9.68 billion in FY2024 (-1.6%), $9.84 billion in FY2023 (-3.3%), $10.17 billion in FY2022 (-7.4%) and $10.98 billion in FY2021 (-18.3%).
- The Q2 2026 figure marks the highest quarterly Revenue since Q3 2021.
- Compared with a year earlier, Revenue was higher in six of the last eight quarters, with growth averaging 1.8%.
- The best year-over-year quarter for Revenue over five years was Q2 2025 (growth of 7.3%); the worst was Q3 2021 (a decline of 17.7%).
- Per Business Quant data, BIIB's Revenue in the three quarters before Q2 2026 was $2.48 billion (Q1 2026), $2.28 billion (Q4 2025) and $2.53 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 22.97 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 25.40 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 16.99 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 16.61 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 14.41 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 15.38 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 10.05 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 7.80 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 15.03 Bn |
| 10 | Biogen | 37.52 Bn | 24.18 Bn | 1.96 Bn | 2.74 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.74 Bn |
| Mar 31, 2026 | 2.48 Bn |
| Dec 31, 2025 | 2.28 Bn |
| Sep 30, 2025 | 2.53 Bn |
| Jun 30, 2025 | 2.65 Bn |
| Mar 31, 2025 | 2.43 Bn |
| Dec 31, 2024 | 2.45 Bn |
| Sep 30, 2024 | 2.47 Bn |
| Jun 30, 2024 | 2.46 Bn |
| Mar 31, 2024 | 2.29 Bn |
| Dec 31, 2023 | 2.39 Bn |
| Sep 30, 2023 | 2.53 Bn |
| Jun 30, 2023 | 2.46 Bn |
| Mar 31, 2023 | 2.46 Bn |
| Dec 31, 2022 | 2.54 Bn |
| Sep 30, 2022 | 2.51 Bn |
| Jun 30, 2022 | 2.59 Bn |
| Mar 31, 2022 | 2.53 Bn |
| Dec 31, 2021 | 2.73 Bn |
| Sep 30, 2021 | 2.78 Bn |
API Access
Biogen Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=BIIB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "BIIB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=BIIB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();